Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Combining Optical Approaches with Human Inducible Pluripotent Stem Cells in G Protein-Coupled Receptor Drug Screening and Development.

Bourque K, Jones-Tabah J, Mnasri N, Martin RD, Hébert TE.

Biomolecules. 2018 Dec 18;8(4). pii: E180. doi: 10.3390/biom8040180. Review.

2.

Measuring G protein-coupled receptor signalling in the brain with resonance energy transfer based biosensors.

Jones-Tabah J, Clarke PB, Hébert TE.

Curr Opin Pharmacol. 2017 Feb;32:44-48. doi: 10.1016/j.coph.2016.10.008. Epub 2016 Nov 9. Review.

PMID:
27837687
3.

Pharmacological Bypass of Cockayne Syndrome B Function in Neuronal Differentiation.

Wang Y, Jones-Tabah J, Chakravarty P, Stewart A, Muotri A, Laposa RR, Svejstrup JQ.

Cell Rep. 2016 Mar 22;14(11):2554-61. doi: 10.1016/j.celrep.2016.02.051. Epub 2016 Mar 10.

4.

Rapid anti-depressant and anxiolytic actions following dopamine D1-D2 receptor heteromer inactivation.

Shen MY, Perreault ML, Bambico FR, Jones-Tabah J, Cheung M, Fan T, Nobrega JN, George SR.

Eur Neuropsychopharmacol. 2015 Dec;25(12):2437-48. doi: 10.1016/j.euroneuro.2015.09.004. Epub 2015 Sep 18.

PMID:
26431907
5.

A physiological role for the dopamine D5 receptor as a regulator of BDNF and Akt signalling in rodent prefrontal cortex.

Perreault ML, Jones-Tabah J, O'Dowd BF, George SR.

Int J Neuropsychopharmacol. 2013 Mar;16(2):477-83. doi: 10.1017/S1461145712000685. Epub 2012 Jul 25.

Supplemental Content

Loading ...
Support Center